Observational Trial of a Therapeutic Platelet Transfusion Regimen

Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission

NCT02587871 ·Status: WITHDRAWN ·Phase: PHASE2

Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

NCT01656252 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Transfusion Strategy in Hematological Intensive Care Unit

NCT02461264 ·Status: UNKNOWN ·Phase: PHASE3

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia

NCT02665143 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

NCT02519712 ·Status: TERMINATED ·Phase: NA

Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia

NCT01976442 ·Status: COMPLETED

Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

NCT03035422 ·Status: COMPLETED ·Phase: NA

Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML

NCT02229266 ·Status: TERMINATED ·Phase: PHASE2

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408 ·Status: COMPLETED

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

NCT00342316 ·Status: COMPLETED ·Phase: NA

Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia

NCT02844257 ·Status: COMPLETED

Transfusion in Adult Acute Myeloid Leukemia

NCT02899767 ·Status: COMPLETED

Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

NCT00125606 ·Status: TERMINATED ·Phase: PHASE3

All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00151255 ·Status: COMPLETED ·Phase: PHASE3

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)

NCT02428517 ·Status: TERMINATED

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

NCT00266136 ·Status: COMPLETED ·Phase: PHASE3

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

NCT01794169 ·Status: TERMINATED ·Phase: PHASE2

Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

NCT02461537 ·Status: COMPLETED ·Phase: PHASE3

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

NCT01588951 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

NCT00880243 ·Status: COMPLETED ·Phase: PHASE3

The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia

NCT01886651 ·Status: COMPLETED

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

NCT02255162 ·Status: TERMINATED ·Phase: PHASE1

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

NCT07297173 ·Status: RECRUITING ·Phase: PHASE1

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

NCT05224661 ·Status: ACTIVE_NOT_RECRUITING

A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia

NCT00400673 ·Status: COMPLETED ·Phase: PHASE2